CLSA in San Francisco Business Times: California biotech industry group CEO leaving

By   | San Francisco Business Times

Sara Radcliffe, who led the California Life Sciences Association through a merger of two of the state’s largest biotech trade groups, will step down from the job next month.

The South San Francisco-based CLSA appointed Mike Guerra, an executive at companies selling into the sciences, as Radcliffe’s replacement. Guerra. a graduate of San Jose State University, since August has been vice president of the Americas for Avidity Sciences LLC, a water purification and laboratory equipment company in Wisconsin, and spent 14 years with VWR International, a manufacturer and distributor for the life sciences industry.

As BayBio and the California Healthcare Institute merged four years ago, Radcliffe came aboard and built out a team that spent an increasing amount of time in legislative circles in Sacramento and Washington, D.C. The organization, which also has offices in San Diego and Los Angeles, said Radcliffe would “pursue new opportunities.”

Before coming to the CLSA, Radcliffe was executive vice president for health at the Biotechnology Innovation Organization, an international trade group.

“She developed a strong brand and reputation for CLSA, which created substantial impact and influence across the state for the benefit of patients, consumers, CLSA members and our entire sector,” said Bill Newell, the CEO of Sutro Biopharma Inc. and chairman of the CLSA board.

CLSA is one of two groups in the state, along with Biocom, that have laid claim to representing California’s growing legion of life sciences companies, including drug, diagnostics and medical device developers. Those groups have sometimes been at odds while offering similar programs, and Biocom over the past couple of years has pushed from its Southern California roots into the Bay Area.